Valerio De Stefano

Research interests

Publications

• A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

  Leukemia · 2017 · https://doi.org/10.1038/leu.2017.169

• Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

  Blood Cancer Journal · 2015 · https://doi.org/10.1038/bcj.2015.94

• Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies

  European Journal of Internal Medicine · 2015 · https://doi.org/10.1016/j.ejim.2014.12.002

• Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

  European Journal of Epidemiology · 2013 · https://doi.org/10.1007/s10654-013-9825-8

• Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1208500

• Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

  Blood · 2012 · https://doi.org/10.1182/blood-2012-07-444067

• Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

  Blood · 2012 · https://doi.org/10.1182/blood-2012-02-408898

• Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

  Journal of Thrombosis and Haemostasis · 2012 · https://doi.org/10.1111/j.1538-7836.2012.04774.x

• Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

  Haematologica · 2008 · https://doi.org/10.3324/haematol.12053

• Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

  Blood · 2007 · https://doi.org/10.1182/blood-2006-12-064287

• Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

  Journal of Thrombosis and Haemostasis · 2007 · https://doi.org/10.1111/j.1538-7836.2007.02424.x

• Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

  The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)68338-4

• Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera

  Blood · 2006 · https://doi.org/10.1182/blood-2006-08-042515

• The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis

  British Journal of Haematology · 2006 · https://doi.org/10.1111/j.1365-2141.2006.06317.x

• The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

  Journal of Thrombosis and Haemostasis · 2005 · https://doi.org/10.1111/j.1538-7836.2005.01467.x

• Screening for inherited thrombophilia: indications and therapeutic implications.

  PubMed · 2002

• The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199909093411104

• Prothrombin G20210A Mutant Genotype Is a Risk Factor for Cerebrovascular Ischemic Disease in Young Patients

  Blood · 1998 · https://doi.org/10.1182/blood.v91.10.3562

• Epidemiology of Factor V Leiden: Clinical Implications

  Seminars in Thrombosis and Hemostasis · 1998 · https://doi.org/10.1055/s-2007-996025

• Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 Families

  Blood · 1998 · https://doi.org/10.1182/blood.v92.7.2353

• Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

  The American Journal of Medicine · 1996 · https://doi.org/10.1016/s0002-9343(96)00060-5

• Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S

  Thrombosis and Haemostasis · 1994 · https://doi.org/10.1055/s-0038-1648870

Current projects

No projects listed.